InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 5,500+ research and publications.
Research title with ★ indicates InBody recommended paper.

Impact of serum albumin levels on the body fluid response to tolvaptan in chronic kidney disease patients

Masuda et al.
Used Parameters : TBW, ICW, ECW, ECW/TBW

Publication Year : 2019

Country : Japan

Journal : International Urology and Nephrology

Purpose Tolvaptan exerts an aquaretic effect by blocking vasopressin V2 receptor. Although tolvaptan ameliorates body fluid retention even in patients with chronic kidney disease (CKD), predictors of body fluid reduction induced by tolvaptan remain unclear. We, therefore, examined the clinical parameters associated with the effect of tolvaptan on fluid volume in CKD patients. Methods Twelve CKD patients (stage 3–5) with fluid retention were treated with tolvaptan in addition to conventional diuretic treatment. Patients were divided into low …
Full text